Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-4-27
pubmed:abstractText
Deleted in colorectal carcinoma (DCC) gene has been as a candidate of tumor suppressor genes, has been identified recently and is thought to relate to the metastatic potential in some cancers. We examined the gene in 60 human gliomas (26 glioblastomas multiforme (GBMs), 16 anaplastic astrocytomas (AAs), 6 low grade astrocytomas (LGAs) of WHO Grade II, and 11 recurrent gliomas) and A172 human GBM cell line by reverse transcription polymerase chain reaction (RT-PCR). Twenty (77%) GBMs, 11 (69%) AAs, and 1 (17%) LGA revealed the reduced or absent DCC expression. Reduced DCC expression was also shown in 10 (91%) recurrent gliomas. Furthermore, in 5 cases with both primary and recurrent GBM, the DCC expressions of all recurrent tumors were lower than those of primary tumors. No significant correlation between DCC expression and Mib-1 labeling index was confirmed. The survival rate of patients without reduced DCC expression was significantly superior to that of patients with reduced DCC expression in overall malignant astrocytic tumors. In GBM and AA separately, DCC expression also tended to correlate with patient's prognosis. These results suggest that reduced DCC expression is an important marker in tumor malignancy and recurrence in astrocytic tumors and that may be a useful prognostic factor in patients with malignant astrocytic tumors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0167-594X
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
237-42
pubmed:dateRevised
2005-11-21
pubmed:meshHeading
pubmed-meshheading:10066096-Adolescent, pubmed-meshheading:10066096-Adult, pubmed-meshheading:10066096-Aged, pubmed-meshheading:10066096-Antigens, Nuclear, pubmed-meshheading:10066096-Brain Neoplasms, pubmed-meshheading:10066096-Cell Adhesion Molecules, pubmed-meshheading:10066096-Female, pubmed-meshheading:10066096-Gene Expression, pubmed-meshheading:10066096-Genes, Tumor Suppressor, pubmed-meshheading:10066096-Glioma, pubmed-meshheading:10066096-Humans, pubmed-meshheading:10066096-Immunohistochemistry, pubmed-meshheading:10066096-Ki-67 Antigen, pubmed-meshheading:10066096-Male, pubmed-meshheading:10066096-Middle Aged, pubmed-meshheading:10066096-Nuclear Proteins, pubmed-meshheading:10066096-Receptors, Cell Surface, pubmed-meshheading:10066096-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:10066096-Survival Analysis, pubmed-meshheading:10066096-Tumor Suppressor Proteins
pubmed:year
1998
pubmed:articleTitle
The significance of the expression of tumor suppressor gene DCC in human gliomas.
pubmed:affiliation
Department of Neurosurgery, Gifu University School of Medicine, Japan.
pubmed:publicationType
Journal Article